Forest Road Acquisition Corp. FRX
12.00 0.00 (+0.00%)
At closeJun 28, 2021, 12:00 AM EDT
11.40 Day range 12.33
52-week range unavailable
- Market cap
- 3.75B
- Shares out
- 30.00M
- Volume
- 3.96M
- Open
- 11.36
- Previous close
- 12.00
- Day's range
- 11.40 – 12.33
No chart data for this range yet.
Key statistics
- Enterprise value
- 449.27M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 730.43K
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 20.33%
- 50-day average
- 10.29
- 200-day average
- 10.64
Next earnings
Consensus EPS estimate 0.00.
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 16, 2021 | DA Davidson | init | — | Buy |
| Jun 7, 2021 | Loop Capital | init | — | Hold |
About Forest Road Acquisition Corp.
Forest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York.
- Sector
- Financial Services
- Industry
- Shell Companies
- Country
- United States
- Website
- spacroadone.com
News
Fennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Above 50-Day Moving Average – Here’s What Happened 
Fennec Announces Results of Annual Meeting 
Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting 
Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 
Fennec Pharmaceuticals Inc. (FENC) Q1 2026 Earnings Call Transcript 
Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update 
Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 
Fennec Pharmaceuticals Inc. (FENC) Q4 2025 Earnings Call Transcript 
Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average – Here’s What Happened 
Southpoint Capital Advisors Lp Sells 160,100 Shares of Fennec Pharmaceuticals (TSE:FRX) Stock
Your note
Sign in to keep a note on FRX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Susquehanna International Group, LLP | 3.60% | 1,079,196 | 10.92M | Mar 30, 2021 |
| Weiss Asset Management LP | 1.84% | 551,400 | 5.58M | Mar 30, 2021 |
| Linden Advisors LP | 1.64% | 493,499 | 4.99M | Mar 30, 2021 |
| DSAM Partners (London) Ltd | 1.64% | 492,283 | 4.98M | Mar 30, 2021 |
| Kepos Capital Lp | 1.60% | 480,000 | 4.86M | Mar 30, 2021 |
| Point72 Asset Management, L.P. | 1.53% | 459,882 | 4.65M | Mar 30, 2021 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Managed Portfolio Series- Friess Small Cap Growth Fd | 0.21% | 63,800 | 645.66K | Mar 30, 2021 |
| Highland Fds I-NexPoint Merger Arbitrage Fund | 0.13% | 40,000 | 404.80K | Mar 30, 2021 |
| Fidelity Convertible Securities Fund | 0.10% | 30,943 | 310.67K | Apr 29, 2021 |
| Fidelity Advisor Multi-Asset Income Fund | 0.04% | 12,000 | 120.48K | Apr 29, 2021 |